Aprogen Biologics Inc. (KRX: 003060)
South Korea
· Delayed Price · Currency is KRW 703.00
-32.00 (-4.35%)
Dec 19, 2024, 3:30 PM KST
Aprogen Biologics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -141,774 | -118,270 | 12,639 | 8,103 | 11,253 | -8,315 | Upgrade
|
| Depreciation & Amortization | 19,225 | 21,398 | 2,404 | 2,072 | 1,932 | 1,661 | Upgrade
|
| Loss (Gain) From Sale of Assets | 151,526 | 151,537 | -3.1 | -53.08 | -593.48 | -0.89 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2,271 | 2,271 | 264.15 | 2,134 | 241.5 | 553.33 | Upgrade
|
| Loss (Gain) From Sale of Investments | -18,029 | -38,597 | -1,380 | -1,623 | -2,476 | -1,853 | Upgrade
|
| Loss (Gain) on Equity Investments | -79,335 | -75,012 | -1,353 | -352.2 | -5,375 | 47,443 | Upgrade
|
| Provision & Write-off of Bad Debts | 8,045 | -24.29 | -2,224 | -26.23 | -1,532 | -417.52 | Upgrade
|
| Other Operating Activities | 30,259 | 35,038 | 1,476 | -720.21 | 5,844 | -38,182 | Upgrade
|
| Change in Accounts Receivable | 3,611 | 1,218 | -637.92 | -494.75 | 902.78 | 1,669 | Upgrade
|
| Change in Inventory | -9,480 | -3,284 | -1,180 | -1,023 | -1,606 | -682.13 | Upgrade
|
| Change in Accounts Payable | 992.81 | -2,373 | 313.46 | -155.63 | 272.35 | -247.01 | Upgrade
|
| Change in Income Taxes | 217.8 | 217.8 | - | - | 3.85 | - | Upgrade
|
| Change in Other Net Operating Assets | 4,164 | -7,768 | 15,410 | -14,088 | -779.66 | -914.75 | Upgrade
|
| Operating Cash Flow | -28,305 | -33,651 | 25,728 | -6,227 | 8,088 | 713.73 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 1033.22% | -46.39% | Upgrade
|
| Capital Expenditures | -15,165 | -28,088 | -1,284 | -796.19 | -976.29 | -2,130 | Upgrade
|
| Sale of Property, Plant & Equipment | 23.2 | 16.82 | 16.36 | 66.71 | 51.07 | 0.95 | Upgrade
|
| Cash Acquisitions | -9,223 | -9,223 | - | - | - | - | Upgrade
|
| Divestitures | -500 | - | 3,074 | - | - | 12,555 | Upgrade
|
| Sale (Purchase) of Intangibles | -174.38 | -308.06 | -261.4 | -145.94 | -292.21 | -291.1 | Upgrade
|
| Investment in Securities | -36,545 | -79,690 | 22,197 | 75,048 | -70,507 | -41,009 | Upgrade
|
| Other Investing Activities | 10,099 | 22,086 | -76,742 | -97,329 | -123,544 | -39,595 | Upgrade
|
| Investing Cash Flow | -51,485 | -95,206 | -53,001 | -23,156 | -195,268 | -70,469 | Upgrade
|
| Short-Term Debt Issued | - | 49,610 | 20,500 | - | - | 6,000 | Upgrade
|
| Long-Term Debt Issued | - | 114,611 | - | - | - | - | Upgrade
|
| Total Debt Issued | 92,397 | 164,221 | 20,500 | - | - | 6,000 | Upgrade
|
| Short-Term Debt Repaid | - | -122,110 | -4,000 | - | - | -6,000 | Upgrade
|
| Long-Term Debt Repaid | - | -353.06 | -262.55 | -349.3 | -410.3 | -26,016 | Upgrade
|
| Total Debt Repaid | -150,175 | -122,463 | -4,263 | -349.3 | -410.3 | -32,016 | Upgrade
|
| Net Debt Issued (Repaid) | -57,779 | 41,758 | 16,237 | -349.3 | -410.3 | -26,016 | Upgrade
|
| Issuance of Common Stock | 115,744 | 40,000 | 0.24 | - | 235,376 | 106,068 | Upgrade
|
| Repurchase of Common Stock | -21.73 | -4,425 | - | - | - | - | Upgrade
|
| Other Financing Activities | 36,877 | 37,957 | -455.34 | -0.96 | -13,262 | -1,609 | Upgrade
|
| Financing Cash Flow | 94,821 | 115,289 | 15,782 | -350.26 | 221,704 | 78,443 | Upgrade
|
| Foreign Exchange Rate Adjustments | 7.23 | 11.65 | 25.04 | 11.02 | -24.83 | -21.19 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | - | 0 | -0 | - | -0 | Upgrade
|
| Net Cash Flow | 15,038 | -13,555 | -11,465 | -29,722 | 34,499 | 8,666 | Upgrade
|
| Free Cash Flow | -43,470 | -61,739 | 24,444 | -7,023 | 7,112 | -1,416 | Upgrade
|
| Free Cash Flow Margin | -63.90% | -70.67% | 37.50% | -12.43% | 13.34% | -2.78% | Upgrade
|
| Free Cash Flow Per Share | -468.88 | -978.68 | 604.74 | -176.20 | 223.97 | -86.60 | Upgrade
|
| Cash Interest Paid | 1,273 | 151.04 | 25.77 | 89.51 | 117.14 | 700.17 | Upgrade
|
| Cash Income Tax Paid | 543.11 | -2,485 | 2,115 | 1,810 | 740.06 | 738.71 | Upgrade
|
| Levered Free Cash Flow | 46,558 | 13,979 | 104,474 | -97,245 | -29,721 | -75,346 | Upgrade
|
| Unlevered Free Cash Flow | 49,277 | 16,272 | 104,645 | -97,226 | -29,690 | -73,268 | Upgrade
|
| Change in Net Working Capital | -93,467 | -67,451 | -106,414 | 95,871 | 29,678 | 71,301 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.